139 related articles for article (PubMed ID: 1452338)
1. Proteins with molecular masses of 25 to 40 kilodaltons elicit optimal protective responses against Plasmodium chabaudi adami infection.
Kima PE; Srivastava IK; Long CA
Infect Immun; 1992 Dec; 60(12):5065-70. PubMed ID: 1452338
[TBL] [Abstract][Full Text] [Related]
2. Induction of specific T-cell responses, opsonizing antibodies, and protection against Plasmodium chabaudi adami infection in mice vaccinated with genomic expression libraries expressed in targeted and secretory DNA vectors.
Rainczuk A; Scorza T; Smooker PM; Spithill TW
Infect Immun; 2003 Aug; 71(8):4506-15. PubMed ID: 12874330
[TBL] [Abstract][Full Text] [Related]
3. A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design.
Amante FH; Crewther PE; Anders RF; Good MF
J Immunol; 1997 Dec; 159(11):5535-44. PubMed ID: 9548494
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with a Plasmodium chabaudi adami multivalent DNA vaccine cross-protects A/J mice against challenge with P. c. adami DK and virulent Plasmodium chabaudi chabaudi AS parasites.
Scorza T; Grubb K; Cambos M; Santamaria C; Tshikudi Malu D; Spithill TW
Int J Parasitol; 2008 Jun; 38(7):819-27. PubMed ID: 18062974
[TBL] [Abstract][Full Text] [Related]
5. Immunity to erythrocytic stages of malarial parasites.
Long CA; Daly TM; Kima P; Srivastava I
Am J Trop Med Hyg; 1994; 50(4 Suppl):27-32. PubMed ID: 7909653
[TBL] [Abstract][Full Text] [Related]
6. Induction of strain-transcending immunity against Plasmodium chabaudi adami malaria with a multiepitope DNA vaccine.
Scorza T; Grubb K; Smooker P; Rainczuk A; Proll D; Spithill TW
Infect Immun; 2005 May; 73(5):2974-85. PubMed ID: 15845504
[TBL] [Abstract][Full Text] [Related]
7. CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization.
Xu H; Hodder AN; Yan H; Crewther PE; Anders RF; Good MF
J Immunol; 2000 Jul; 165(1):389-96. PubMed ID: 10861076
[TBL] [Abstract][Full Text] [Related]
8. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
Rainczuk A; Scorza T; Spithill TW; Smooker PM
Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
[TBL] [Abstract][Full Text] [Related]
9. The protective efficacy of MSP4/5 against lethal Plasmodium chabaudi adami challenge is dependent on the type of DNA vaccine vector and vaccination protocol.
Rainczuk A; Smooker PM; Kedzierski L; Black CG; Coppel RL; Spithill TW
Vaccine; 2003 Jun; 21(21-22):3030-42. PubMed ID: 12798647
[TBL] [Abstract][Full Text] [Related]
10. Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.
Burns JM; Flaherty PR; Nanavati P; Weidanz WP
Infect Immun; 2004 Oct; 72(10):5605-12. PubMed ID: 15385457
[TBL] [Abstract][Full Text] [Related]
11. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes.
Crewther PE; Matthew ML; Flegg RH; Anders RF
Infect Immun; 1996 Aug; 64(8):3310-7. PubMed ID: 8757869
[TBL] [Abstract][Full Text] [Related]
12. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi.
Anders RF; Crewther PE; Edwards S; Margetts M; Matthew ML; Pollock B; Pye D
Vaccine; 1998; 16(2-3):240-7. PubMed ID: 9607037
[TBL] [Abstract][Full Text] [Related]
13. Gamma delta T cells function in cell-mediated immunity to acute blood-stage Plasmodium chabaudi adami malaria.
van der Heyde HC; Elloso MM; Chang WL; Kaplan M; Manning DD; Weidanz WP
J Immunol; 1995 Apr; 154(8):3985-90. PubMed ID: 7706737
[TBL] [Abstract][Full Text] [Related]
14. Identification of antigenically active tryptic fragments of apical membrane antigen-1 (AMA1) of Plasmodium chabaudi malaria: strategies for assembly of immunologically active peptides.
Salvatore D; Hodder AN; Zeng W; Brown LE; Anders RF; Jackson DC
Vaccine; 2002 Oct; 20(29-30):3477-84. PubMed ID: 12297393
[TBL] [Abstract][Full Text] [Related]
15. Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1.
Burns JM; Flaherty PR; Romero MM; Weidanz WP
Vaccine; 2003 May; 21(17-18):1843-52. PubMed ID: 12706668
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific, interleukin 2-propagated T lymphocytes confer resistance to a murine malarial parasite, Plasmodium chabaudi adami.
Brake DA; Weidanz WP; Long CA
J Immunol; 1986 Jul; 137(1):347-52. PubMed ID: 2423609
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium chabaudi: immunogenicity of a highly antigenic glutamate-rich protein.
Wiser MF; Giraldo LE; Schmitt-Wrede HP; Wunderlich F
Exp Parasitol; 1997 Jan; 85(1):43-54. PubMed ID: 9024201
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium chabaudi chabaudi: a monoclonal antibody raised against soluble antigens present in the plasma of infected mice recognizes a 250-kDa schizont glycoprotein that is secreted during schizogony.
Furtado GC; Moura IC; Pudles J; Alvarez JM; D'Império Lima MR
Exp Parasitol; 1999 Jan; 91(1):97-100. PubMed ID: 9920048
[No Abstract] [Full Text] [Related]
19. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
Rotman HL; Daly TM; Long CA
Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
[TBL] [Abstract][Full Text] [Related]
20. Isolation of merozoite rhoptries, identification of novel rhoptry-associated proteins from Plasmodium yoelii, P. chabaudi, P. berghei, and conserved interspecies reactivity of organelles and proteins with P. falciparum rhoptry-specific antibodies.
Sam-Yellowe TY; Del Rio RA; Fujioka H; Aikawa M; Yang JC; Yakubu Z
Exp Parasitol; 1998 Jul; 89(3):271-84. PubMed ID: 9676705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
